Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia

New treatments for adults with acute lymphoblastic T-cell leukemia (T-ALL) are urgently needed, as the current rate of overall remission in these patients is only about 40 percent. We recently showed the potential therapeutic benefit of the pegylated-human-arginase I (peg-Arg I) in T-ALL. However, t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Morrow, K, Hernandez, CP, Raber, P, Valle, L Del, Wilk, AM, Majumdar, S, Wyczechowska, D, Reiss, K, Rodriguez, PC
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3594435/
https://ncbi.nlm.nih.gov/pubmed/22926702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2012.247
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller